Financhill
Back

Zymeworks 10K Form

Buy
79

ZYME
Zymeworks

Last Price:
14.70
Seasonality Move:
12.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive ZYME News And Ratings

See the #1 stock for the next 7 days that we like better than ZYME

ZYME Financial Statistics

Sales & Book Value

Annual Sales: $76.01M
Cash Flow: $-6.88M
Price / Cash Flow: 0
Annual Sales: $5.27
Price / Book: 2.75

Profitability

EPS (TTM): -1.49000
Net Income (TTM): $-113.67M
Gross Margin: $11.09M
Return on Equity: -27.06%
Return on Assets: -21.1%

Zymeworks Earnings Forecast

Key Zymeworks Financial Ratios

  • The Gross Profit Margin over the past 4 years for ZYME is 21.43%.
  • The Selling, General & Administrative Expenses for ZYME have been equal to 92.62% of Gross Profit Margin.
  • The Research & Development expenses have been 188.94% of Revenue.
  • The Interest Expense is -0.46% of Operating Income.
  • The Net Earning history of ZYME is -156.13% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 3 years.

Zymeworks Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ZYME
CUSIP: 98985W
Website: zymeworks.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.1
Quick Ratio: 3.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ZYME Technical Analysis vs Fundamental Analysis

Buy
79
Zymeworks (ZYME) is a Buy

Is Zymeworks a Buy or a Sell?

  • Zymeworks stock is rated a Buy
    The current Zymeworks [ZYME] share price is $14.66. The Score for ZYME is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.